Local health care providers say if you’re showing signs of a respiratory illness, you must wear a mask in area urgent cares ...

GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...

Coughing can be caused by pollution or viral infections. Experts explain key differences, warning signs and when simple care ...

The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.

Misunderstanding COPD and asthma can be risky. Recognising the difference in the condition, treatment options, and the need for early intervention is important.

According to the latest PharmaTrac data, the respiratory unit sales rose 5.2% versus 2.6% for the overall IPM, while value ...

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

“For most people, all ages, the classic symptoms are going to be a pretty abrupt onset of fever, headaches, body aches are ...

CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...

Pneumonia is an infection that affects one or both lungs. The disease can range from mild to severe and can be fatal. It is typically ...

Discover effective home remedies and preventive measures to combat respiratory issues this winter with our quick guide.

China NMPA approves GSK’s Nucala to treat adults with chronic obstructive pulmonary disease: London, UK Tuesday, January 6, 2026, 10:00 Hrs [IST] GSK plc announced that China’ ...